Freedman Financial Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,618
Closed -$386K 265
2022
Q1
$386K Hold
4,618
0.27% 45
2021
Q4
$354K Hold
4,618
0.24% 45
2021
Q3
$347K Hold
4,618
0.25% 44
2021
Q2
$359K Sell
4,618
-194
-4% -$14.4K 0.27% 42
2021
Q1
$354K Buy
4,812
+51
+1% +$3.76K 0.29% 39
2020
Q4
$372K Buy
+4,761
New +$364K 0.33% 38

Other funds holding MRK

Freedman Financial Associates's MRK Position: Q2 2022 in Review

Freedman Financial Associates sold out of Merck (MRK) in Q2 2022, closing a stake of 4,618 shares — an estimated $386K sold.

Freedman Financial Associates first reported a position in MRK in Q4 2020 and held it in 6 quarters. The position peaked at $386K in Q1 2022. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Freedman Financial Associates reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 4,618 Merck shares in Q2 2022, an estimated $386K.
  • Freedman Financial Associates first reported a position in Merck in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Merck position peaked at $386K in Q1 2022.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.